首页> 美国卫生研究院文献>Pharmaceutics >Effect of a Cationic Surfactant on Microemulsion Globules and Drug Release from Hydrogel Contact Lenses
【2h】

Effect of a Cationic Surfactant on Microemulsion Globules and Drug Release from Hydrogel Contact Lenses

机译:阳离子表面活性剂对微乳小球和水凝胶隐形眼镜药物释放的影响

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The present study evaluates the in vitro release of diclofenac sodium (DFNa) from contact lenses based on poly-2-hydroxyethyl methacrylate (pHEMA) hydrogels containing an embedded microemulsion to extend release duration. The oil (ethyl butyrate)-in-water microemulsion systems are prepared with two non-ionic surfactants, Brij 97 or Tween 80, together with a long-alkyl chain cationic surfactant, cetalkonium chloride (CKC). Without CKC, Brij 97 or Tween 80-based microemulsions showed average droplet sizes of 12 nm and 18 nm, respectively. The addition of CKC decreased the average droplet sizes to 2–5 nm for both non-ionic surfactants. Such significant reduction in the average droplet size corresponds to an increase in the DFNa release duration as revealed by the in vitro experiments. Contact lens characterization showed that important properties such as optical transparency and water content of Brij 97-based contact lenses with cationic microemulsions was excellent. However, the optical transparency of the corresponding Tween 80 based contact lenses was unsatisfactory. The results indicate that cationic microemulsion-laden contact lenses can benefit from combinatory effects of microemulsions and cationic surfactant at low CKC weight percentage, e.g., with the release of 70% of the drug in 45, 10, and 7 h for B97-CKC-0.45%, CKC-0.45%, and control lenses, respectively. However, the microemulsion effect on extending DFNa release became negligible at the highest CKC weight percentage (1.8%).
机译:本研究评估了双氯芬酸钠(DFNa)从含嵌入式微乳状液以延长释放持续时间的聚甲基丙烯酸2-羟乙酯(pHEMA)水凝胶为基础的隐形眼镜的体外释放。用两种非离子型表面活性剂Brij 97或Tween 80,以及长烷基链阳离子表面活性剂氯化乙草胺(CKC)制备水(丁酸乙酯)水微乳液体系。在没有CKC的情况下,基于Brij 97或Tween 80的微乳液的平均液滴尺寸分别为12 nm和18 nm。两种非离子表面活性剂的加入,CKC可使平均液滴尺寸降至2–5 nm。如体外实验所揭示的,平均液滴尺寸的这种显着减小对应于DFNa释放持续时间的增加。隐形眼镜的表征表明,具有阳离子微乳液的Brij 97基隐形眼镜的重要性能,如光学透明度和水含量非常好。然而,相应的基于Tween 80的隐形眼镜的光学透明性不能令人满意。结果表明,载有阳离子微乳状液的隐形眼镜可在低CKC重量百分比的情况下受益于微乳状液和阳离子表面活性剂的联合作用,例如B97-CKC-在45、10和7小时内释放70%的药物0.45%,CKC-0.45%和对照镜片。但是,在最高CKC重量百分比(1.8%)下,微乳液对延长DFNa释放的影响可忽略不计。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号